NCT06363214|Unknown
Impact of Patient Blood Management (PBM) at the Schulthess Clinic
PBM
Loading search results
PBM
Sponsor study identifier
observational
16,000
0 countries
N/A
Study Start
May 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Aim of this study is to analyze the transfusion requirements of allogenic blood products at the Schulthess Clinic for patients that had major orthopedic or major spine surgery between 2019 and 2024 order to identify patients at risk for transfusion. Moreover, impact of transfusion requirements and other measures of PBM on patient outcomes will be assessed. These data are required to further improve PBM at the Schulthess Clinic.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 9, 2024
Actual (reported)April 12, 2024
Actual (reported)May 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
February 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Perioperative transfusion rates
Administration of red blood cells, fresh frozen plasma and platelet concentrates (units)
2019-2024
Risk factors for perioperative transfusion Risk factors for perioperative transfusion Risk factorsfor perioperative transfusion
Identification of patient groups with increased transfusion rates
2019-2024
Perioperative rates of coagulation products administered
2019-2024
Clinical outcomes
2019-2024
Perioperative optimization of hemoglobin level, perioperative minimization of blood loss, increase of anemia tolerance
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients undergoing elective major orthopedic or spine surgery at the Schulthess Clinic between 2019 and 2024.
Christoph K Hofer, MD
Schulthess Klinik
First Submitted
April 9, 2024
First Posted
April 12, 2024
Study Start
May 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 2025
Study on the Relationship of Arterial-venous Oxygen Difference and Postoperative Complications After Cardiac Surgery.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 16, 2024
Record last verified: 2024-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: